We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$80.3M
AUM Growth
+$6.68M
Cap. Flow
-$15.7M
Cap. Flow %
-19.56%
Top 10 Hldgs %
78.33%
Holding
71
New
23
Increased
2
Reduced
8
Closed
18

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Communication Services 15.54%
3 Energy 6.49%
4 Technology 5.56%
5 Consumer Staples 2.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLXP
26
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$116K 0.14%
29,282
-16,814
-36% -$68.7K
SHIPW
27
DELISTED
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
$97K 0.12%
1,180,400
CHEKZ
28
DELISTED
Check-Cap Ltd. Series C Warrant
CHEKZ
$93K 0.12%
+136,364
New +$106K
BVXVW
29
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$92K 0.11%
72,800
SGLBW
30
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
$75K 0.09%
214,500
-800
-0.4% -$377
QUIK icon
31
QuickLogic
QUIK
$211M
$67K 0.08%
+4,146
New +$79.4K
RXIIW
32
DELISTED
RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021
RXIIW
$55K 0.07%
221,056
-630
-0.3% -$273
IMRNW
33
DELISTED
Immuron Limited Warrants
IMRNW
$47K 0.06%
15,041
-7,000
-32% -$24K
IMNP
34
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$47K 0.06%
+251,029
New +$71K
CLRBZ
35
DELISTED
Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
$39K 0.05%
207,500
RSLS
36
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
$38K 0.05%
+118
New +$101K
APOPW
37
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$25K 0.03%
12,570
AMRHW
38
DELISTED
Ameri Holdings, Inc. Warrant
AMRHW
$21K 0.03%
125,503
SNGXW
39
DELISTED
Soligenix, Inc. Warrant
SNGXW
$17K 0.02%
61,000
APDNW
40
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
$9K 0.01%
31,407
CYTXZ
41
DELISTED
Cytori Therapeutics Inc Series S Warrant
CYTXZ
$8K 0.01%
+259,200
New +$11.2K
BNTCW
42
DELISTED
Benitec Biopharma Limited
BNTCW
$6K 0.01%
50,000
MYNDW
43
DELISTED
MYnd Analytics, Inc. Warrant
MYNDW
$3K ﹤0.01%
13,700
ONTXW
44
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$2K ﹤0.01%
173,112
ADXSW
45
DELISTED
Advaxis Inc Warrants
ADXSW
$2K ﹤0.01%
15,150
NSPRZ
46
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$1K ﹤0.01%
48,000
EYEGW
47
DELISTED
Eyegate Pharmaceuticals, Inc. Warrants
EYEGW
$1K ﹤0.01%
12,900
ADC icon
48
Agree Realty
ADC
$9.66B
-111,649
Closed -$5.36M
AFMD
49
DELISTED
Affimed
AFMD
-36,046
Closed -$667K
AKBA icon
50
Akebia Therapeutics
AKBA
$338M
-327,457
Closed -$3.12M

Similar funds

CVI Holdings's Q2 2018 Portfolio in Review

As of Q2 2018, CVI Holdings held 71 positions worth $80.3M, up 9.1% from $73.7M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

CVI Holdings withdrew a net $15.7M in Q2 2018, closing 18 positions and reducing 8 holdings. Its most notable exit was Agree Realty, an estimated $5.36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Communication Services and Energy.

Against the trend, CVI Holdings opened a new position in Novavax worth $4.44M.

  • CVI Holdings's largest Q2 2018 buy was Novavax: 165,780 shares worth $4.44M.
  • CVI Holdings added most to Eros Media World PLC in Q2 2018, an estimated $1.76M increase.
  • CVI Holdings's biggest Q2 2018 reduction was SCYNEXIS, cutting an estimated $1.59M.
  • CVI Holdings fully exited Agree Realty in Q2 2018, selling an estimated $5.36M.
  • CVI Holdings's ten largest holdings make up 78% of its $80.3M portfolio in Q2 2018.
  • CVI Holdings opened 23 new positions and closed 18 in Q2 2018.
  • CVI Holdings's portfolio value rose 9.1% quarter-over-quarter to $80.3M.

Based on CVI Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.